Dr. Stephen Collins is a gastroenterologist and a researcher at McMaster University in Canada. Collins’ recent studies on the functional relevance of the gut microbiota, in collaboration with Dr. R. DePalma & Dr. P. Bercik, were recently presented at the
At the occasion of the "New therapies in coeliac disease" conference hosted by Columbia University in New-York on March 20, 2014, Dr. Elena Verdú, our expert in Nutrition, is sharing with us the last trends in research in the field of
A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis.
10 Jan 2014by Philippe Marteau
Machiels et al. recently described that the composition of the faecal microbiota of patients suffering from ulcerative colitis differs from that of healthy individuals: they found a reduction in two well-known butyrate-producing bacteria of the Firmicutes phylum, Roseburia hominis and
Speakers: Dirk Haller (Germany), Balfour Sartor (USA) Prof. Haller started his presentation by pointing out that “dysbiosis” is not a good term, because nobody knows what dysbiosis really means. To be able to understand what dysbiosis is, you would
Press release – Gut microbiota research: pinpointing a moving target
20 Feb 2013by GMFH Editing Team
(27 February 2013) Although considerable progress has been made in determining the impact of the gut microbiota on the development of inflammatory bowel disease (IBD) and other gastrointestinal (GI) diseases, the detailed study and understanding of the composition and effects
Press release – Faecal microbiota transplantation cures gastrointestinal diseases
20 Feb 2013by GMFH Editing Team
Stool transplants highly efficient for Clostridium difficile infections and other gastrointestinal conditions — online press conference at 2nd World Summit “Gut Microbiota For Health” held today (26 February 2013) Clostridium difficile infections have developed into a virtual pandemic over the
